Immunohistochemical Nuclear Expression of β-Catenin as a Surrogate of CTNNB1 Exon 3 Mutation in Endometrial Cancer-Reference-Cited by-同舟云学术

Immunohistochemical Nuclear Expression of β-Catenin as a Surrogate of CTNNB1 Exon 3 Mutation in Endometrial Cancer

Published:2019-02-02 Issue:5 Volume:151 Page:529-538
ISSN:0002-9173
Container-title:American Journal of Clinical Pathology
language:en
Short-container-title:

Author:

Travaglino Antonio¹,Raffone Antonio²^ORCID,Saccone Gabriele²,De Luca Caterina³,Mollo Antonio²,Mascolo Massimo¹,De Placido Giuseppe²,Insabato Luigi¹,Zullo Fulvio²

Affiliation:

1. Anatomic Pathology Unit, Department of Advanced Biomedical Sciences, School of Medicine

2. Gynecology and Obstetrics Unit, Department of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine

3. Molecular Biology Unit, Department of Public Health, School of Medicine, University of Naples Federico II, Naples, Italy

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/ajcp/article-pdf/151/5/529/28265019/aqy178.pdf

Reference41 articles.

1. Cancer statistics, 2015;Siegel;CA Cancer J Clin.,2015

2. A clinically applicable molecular-based classification for endometrial cancers;Talhouk;Br J Cancer.,2015

3. Hysteroscopic endometrial focal resection followed by levonorgestrel intrauterine device insertion as a fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial cancer: a retrospective study [published online July 11, 2018];Giampaolino;J Minim Invasive Gynecol.

4. Poor interobserver reproducibility in the diagnosis of high-grade endometrial carcinoma;Gilks;Am J Surg Pathol.,2013

5. Histotype-genotype correlation in 36 high-grade endometrial carcinomas;Hoang;Am J Surg Pathol.,2013

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mutation profile and molecular heterogeneity in mismatch repair deficient endometrial carcinoma;2024-06-26

2. The evolving molecular characterisation, histological criteria and nomenclature of adenoid ameloblastoma as a World Health Organisation tumour type;Histopathology;2024-06-24

3. Molecular profiling of primary endometrioid endometrial cancer and matched lung metastases: CTNNB1 mutation as a potential driver;Gynecologic Oncology Reports;2024-06

4. Evaluation of prognostic potential of β-catenin and L1CAM expression according to endometrial cancer risk group;Gynecologic Oncology;2024-05

5. Study Design and Rationale of the ECMC-GART Phase 3 Clinical Study: Early-Stage Endometrial Cancer Based on Molecular Classification and Traditional Risk Stratification to Guide Adjuvant Radiotherapy Decisions;2024-04-08